Reuters Analysis Finds Average Launch Price For Drugs Approved By FDA in 2025… Read More
Lawmakers Advance Bipartisan Solutions to Hold Big Pharma Accountable for… Read More
Big Pharma’s Arguments Against Bipartisan, Market-Based Solutions to Foster… Read More
U.S. House Judiciary Subcommittee Hearing Builds Bipartisan Momentum for ETHIC… Read More
Health Care Leaders and Policy Experts Agree Bipartisan, Market-Based… Read More
Report Finds List Prices for Best-Selling Medicare Part D Prescription Drugs… Read More
Big Pharma Hides Behind False Innovation Rhetoric to Maintain Rampant Abuse of… Read More
Analysis Details How Big Pharma’s Patent Abuse Delays Generic and Biosimilar… Read More
Pfizer CEO Highlights Delayed Competition on Blockbuster Drug as Reason to Be… Read More
AbbVie CEO Touts Patent Abuse to Extend Exclusivity on Blockbuster Skyrizi,… Read More
Sanofi Touts Patent Thickets, Legal Strategy to Block Competition to Dupixent… Read More
Analysis Demonstrates Tremendous Cost of Anti-Competitive Tactics Like Patent… Read More